Edition:
United States

Amedica Corp (AMDA.OQ)

AMDA.OQ on NASDAQ Stock Exchange Capital Market

0.35USD
22 Jun 2017
Change (% chg)

$-0.01 (-2.81%)
Prev Close
$0.36
Open
$0.37
Day's High
$0.37
Day's Low
$0.33
Volume
167,434
Avg. Vol
87,560
52-wk High
$1.62
52-wk Low
$0.26

AMDA.OQ

Chart for AMDA.OQ

About

Amedica Corporation is a commercial biomaterial company. The Company is a vertically integrated silicon nitride orthopedic medical device manufacturer. It is focused on using its silicon nitride ceramic technology platform to develop, manufacture and sell a range of medical devices. It is also engaged in developing wear- and... (more)

Overall

Beta: -2.11
Market Cap(Mil.): $12.69
Shares Outstanding(Mil.): 36.26
Dividend: --
Yield (%): --

Financials

  AMDA.OQ Industry Sector
P/E (TTM): -- 34.02 19.12
EPS (TTM): -1.50 -- --
ROI: -96.52 13.01 -5.05
ROE: -295.88 15.52 -4.29

BRIEF-Amedica announces delayed filing of quarterly report on form 10-Q

* Amedica announces delayed filing of quarterly report on form 10-Q and receipt of nasdaq letter

May 26 2017

BRIEF-Amedica Corp files for non-timely 10-Q

* Amedica Corp - co has not yet completed certain financial and other information necessary for an accurate and full completion of the quarterly report Source text - (http://bit.ly/2qobkui) Further company coverage:

May 16 2017

BRIEF-Amedica announces regulatory clearance to market and sell Valeo in Australia

* Amedica announces regulatory clearance to market and sell Valeo silicon nitride spinal implants in Australia

Apr 24 2017

BRIEF-Amedica concludes unaudited condensed financials

* Amedica - on April 13 concluded unaudited condensed financials filed on Nov. 14, 2016 for quarter ended Sept. 30, 2016 should no longer be relied upon

Apr 19 2017

BRIEF-Amedica Corp files for non-timely 10-K

* Amedica Corp files for non-timely 10-K - sec filing Source text (http://bit.ly/2oiKzXU) Further company coverage:

Mar 31 2017

BRIEF-Amedica granted extension by Nasdaq to regain compliance with minimum bid price rule

* Amedica granted 180-day extension by Nasdaq to regain compliance with minimum bid price rule Source text for Eikon: Further company coverage:

Feb 15 2017

CORRECTED-BRIEF-Sabby Management reports 5.79 pct passive stake in Amedica Corp

* Sabby Management LLC reports 5.79 percent passive stake in Amedica Corp as of Jan 19 - sec filing Source text : http://bit.ly/2iOZAda Further company coverage:

Jan 19 2017

BRIEF-AMEDICA ANNOUNCES PRICING OF PUBLIC OFFERING

* AMEDICA ANNOUNCES PRICING OF PUBLIC OFFERING TO RAISE $4.5 MILLION

Jan 19 2017

BRIEF-Amedica announces proposed public offering of common stock and warrants

* Amedica announces proposed public offering of common stock and warrants

Jan 18 2017

More From Around the Web

Competitors

Earnings vs. Estimates